Mining Prognostic Significance of MEG3 in Human Breast Cancer Using Bioinformatics Analysis
Author(s) -
Xiangrong Cui,
Qin Yi,
Xuan Jing,
Yue Huang,
Jie Tian,
Chunlan Long,
Zhongping Xiang,
Jianping Liu,
Chunmin Zhang,
Bin Tan,
Yasha Li,
Jing Zhu
Publication year - 2018
Publication title -
cellular physiology and biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.486
H-Index - 87
eISSN - 1421-9778
pISSN - 1015-8987
DOI - 10.1159/000493956
Subject(s) - breast cancer , meg3 , carcinogenesis , estrogen receptor , biology , oncology , medicine , cancer research , methylation , cancer , bioinformatics , gene , genetics , downregulation and upregulation , long non coding rna
Maternally expressed gene 3 (MEG3) is an imprinted gene with maternal expression, which may function as a tumor suppressor by inhibiting angiogenesis. To identify the prognostic value of MEG3 in breast cancer, systematic analysis was performed in this study.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom